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The structure of Vibrio cholerae FadR (VcFadR) complexed with the ligand oleoyl-CoA
suggests an additional ligand-binding site. However, the fatty acid metabolism and
its regulation is poorly addressed in Vibrio alginolyticus, a species closely-related to
V. cholerae. Here, we show crystal structures of V. alginolyticus FadR (ValFadR) alone
and its complex with the palmitoyl-CoA, a long-chain fatty acyl ligand different from the
oleoyl-CoA occupied by VcFadR. Structural comparison indicates that both VcFadR
and ValFadR consistently have an additional ligand-binding site (called site 2), which
leads to more dramatic conformational-change of DNA-binding domain than that of the
E. coli FadR (EcFadR). Isothermal titration calorimetry (ITC) analyses defines that the
ligand-binding pattern of ValFadR (2:1) is distinct from that of EcFadR (1:1). Together
with surface plasmon resonance (SPR), electrophoresis mobility shift assay (EMSA)
demonstrates that ValFadR binds fabA, an important gene of unsaturated fatty acid
(UFA) synthesis. The removal of fadR from V. cholerae attenuates fabA transcription
and results in the unbalance of UFA/SFA incorporated into membrane phospholipids.
Genetic complementation of the mutant version of fadR (142, 136-177) lacking site 2
cannot restore the defective phenotypes of 1fadR while the wild-type fadR gene and
addition of exogenous oleate can restore them. Mice experiments reveals that VcFadR
and its site 2 have roles in bacterial colonizing. Together, the results might represent an
additional example that illustrates the Vibrio FadR-mediated lipid regulation and its role
in pathogenesis.
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INTRODUCTION
The Vibrionaceae is a family of Gram-negative bacteria inhabiting fresh/salt water environments
that comprised a collection of pathogenic species (Thompson et al., 2005). V. cholerae is
the notorious cause of cholera transmitted by contaminated water. V. parahaemolyticus is a
zoonotic pathogen that cause serious food-borne infections from poorly-cooked sea-food (e.g.,
gastroenteritis and septicemia). Both V. vulnificus and V. alginolyticus are opportunistic bacterial
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pathogens since they cause severe wound infection and even
fatal septicemia. The two major virulence determinants of
Vibrio cholerae referred to toxin-coregulated pilus (TCP) (Taylor
et al., 1987) and cholera toxin (CT) (Matson et al., 2007),
which are coordinated by two independent activators ToxR,
a transmembrane regulatory protein (Miller et al., 1987), and
ToxT, a member of AraC family transcription factors (Champion
et al., 1997). It seems true that the regulated expression of
fatty acid metabolism is implicated into Vibrio pathogenicity in
that (i) inactivation of fadR impairs virulence of V. vulnificus
in mice (Brown and Gulig, 2008); (ii) the disruption of fadD
gene encoding a long-chain fatty acyl coenzyme A ligase affected
production of virulence factors, CtxAB and TcpA (Ray et al.,
2011); and (iii) unsaturated fatty acids from bile interfered with
bacterial mobility via remodeling bacterial membrane structure
(Giles et al., 2011) and inhibited the expression of virulence
factors (CtxAB and TcpA) by decreased DNA-binding activity
of ToxT in V. cholerae (Brown and Gulig, 2008; Giles et al.,
2011; Yang et al., 2013; Kovacikova et al., 2017). More recently,
Kovacikova et al. (2017) proposed that the V. cholerae FadR
controls the expression of the virulence cascade by indirect-
regulation of ToxT via two different mechanisms (Kovacikova
et al., 2017). In contrast to the E. coli FadR paradigm, its Vibrio
homologs with an insert of 40 aa exhibit stronger ability of
binding LC acyl-CoA thioesters (Heidelberg et al., 2000; Iram
and Cronan, 2005). The structural mechanism of V. cholerae
FadR relies on an additional acyl-CoA ligand binding site formed
mainly by the 40-residue insert (Shi et al., 2015).
The paradigm E. coli FadR regulator, belonging to a GntR-
type transcription factor, is a dimeric protein that is composed
of an N-terminal DNA-binding motif and a C-terminal ligand-
interaction domain (van Aalten et al., 2000, 2001; Xu et al., 2001).
The E. coli FadR acts as a moderate global regulator in that it
negatively regulates more than 12 fad genes [such as fadBA (Iram
and Cronan, 2006), fadM (Feng and Cronan, 2009a), fadH (Feng
and Cronan, 2010), etc.] and it positively regulates, the two key
genes (fabA and fabB) of UFA synthesis (Henry and Cronan,
1992; Campbell and Cronan, 2001). In addition, FadR also
activates the fabHDG operon required for SFA synthesis in E. coli
(My et al., 2013). The physiological ligand of FadR is LC fatty
acyl-CoA thioesters. Upon FadR binding of these ligands, FadR
is released from all its DNA-binding sites (Henry and Cronan,
1992; Cronan, 1997). This mechanism explains the fatty acid-
inducible expression of fad regulon (Overath et al., 1969; Klein
et al., 1971) plus the fatty acids-mediated repression of fabA/fabB
expression (Henry and Cronan, 1991; Campbell and Cronan,
2001). Although the structural basis for E. coli FadR regulation is
well understood from the x-ray crystal structures of E. coli FadR
alone (van Aalten et al., 2000), bound DNA (van Aalten et al.,
2001; Xu et al., 2001) and in a complex with its ligand myristoyl-
CoA (van Aalten et al., 2001), further investigations unexpectedly
suggested that FadR orthologs display appreciable functional
diversity (Iram and Cronan, 2005) in that FadR proteins from
diverse Y-proteobacteria showed large differences in the ability to
regulate E. coli fad regulon.
In views of genomic context of lipid metabolism (Figure 1),
the Vibrio species, like V. cholerae, seem quite different from
E. coli (and S. enterica) because they have two chromosomes that
together encode all the enzymes of fatty acid metabolism. Unlike
the paradigm “FadL-FadD” fatty acid transport system in E. coli,
Vibrio encodes three fadL orthologs only one of which has the
FadR-binding site recognized by Vibrio (Figure 1A) (Heidelberg
et al., 2000). This might facilitate more efficient scavenging low
level of fatty acids from the dilute marine environment (van den
Berg et al., 2004). Relative to E. coli which has 12 FadR-regulated
genes (Figures 1B–E), the predicted FadR-binding palindrome is
detected in only 7 Vibrio genes including 5 known fad/fab genes,
suggesting contraction of fad regulon (Figures 1F,G) (Zhang
et al., 2015; Gao et al., 2016). Of note, theVibrio plsB gene is under
FadR control (Figures 1F,G), whereas the E. coli counterpart has
no effect on this gene (Feng and Cronan, 2011). In contrast to
the FadR of E. coli and S. enterica, all the three Vibrio FadR
proteins (ValFadR forV. alginolyticus, VcFadR forV. cholerae and
VpFadR for V. parahaemolyticus) consistently have an unusual
insert of 40 residues (Figure S1), one of which had already been
demonstrated to constitute an additional ligand-binding site in
the case of VcFadR (Shi et al., 2015). It explains at least (if not all)
why V. cholerae has potent ability in fatty acid sensing.
Given that knowledge of fatty acid metabolism in
V. alginolyticus is limited, here we report structural and
functional characterization of V. alginolyticus FadR. The
snapshot of the ValFadR-ligand complex structure also illustrates
an additional ligand-binding site. Mice infection experiments
suggest that both FadR and the second ligand-binding site might
be required for bacterial successful colonization. Together, these
results constitute an additional example facilitating us to further
understand Vibrio fatty acid signaling by FadR and its relevance
to bacterial virulence. It is rational that development of small
molecule inhibitors targeting the FadR-mediated fatty acid
sensing might be a promising strategy against Vibrio infections.
RESULTS
Characterization of the V. alginolyticus
FadR
We are interested in probing if similar scenarios occur in
V. alginolyticus. Thus, four types of FadR proteins (namely
ValFadR, VcFadR, VpFadR, and EcFadR), were over-expressed
and purified with nickel-affinity column, whose purity was
judged by SDS-PAGE (Figure S2C). Size exclusion analyses
confirmed that all the three Vibrio FadR proteins (ValFadR
and VpFadR, in Figure S2A; VcFadR in Figure S2B) can form
dimeric structure in solution, which is almost identical to that of
EcFadR (Figure S2A). Together with surface plasmon resonance
(SPR)-based detection, EMSA experiments were also applied to
address binding abilities of the putative Vibrio FadR palindromes
(Figures 1C,F,G). A 54 bp of DNA fragment covering the
FadR palindrome in the upstream of the Vibrio fabA gene is
designated herein as fabA probe. In general agreement with
that of EcFadR (Figure 2A), gel shift assays also confirmed that
the fabA probe interacts efficiently with ValFadR (Figure 2D).
Similar scenarios were also seen with the other two Vibrio
FadR regulatory proteins VcFadR (Figure 2B) and VpFadR
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FIGURE 1 | Working model for Vibrio FadR-mediated fatty acid sensing and regulation. (A) Schematic representative for uptake and activation of long-chain fatty
acids by FadL-FadD system of V. cholerae N16961. The long-chain fatty acids are transported by FadL membrane protein from the environment into periplasm and
then activated by inner-membrane associated protein FadD to give LC acyl-CoA in cytosol. Among three putative FadR homologs encoded by V. cholerae N16961
genome, FadL2 (in red) is only one gene with a predicted FadR-binding site. LCFA is an abbreviation of long chain fatty acid. (B) Sequence logo for FadR-specific
palindromes from E. coli MG1655. (C) Sequence logo for FadR-specific palindromes from Vibrio genus. The sequences of the known E. coli FadR sites were sampled
(Continued)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 December 2017 | Volume 7 | Article 513
Gao et al. Characterization of the V. alginolyticus FadR
FIGURE 1 | from E. coli K-12 MG1655 (http://regprecise.lbl.gov/RegPrecise/regulon.jsp?regulon_id=10286), and the putative Vibrio FadR sites were collected from 9
Vibrio species (http://regprecise.lbl.gov/RegPrecise/sites.jsp?regulog_id=1762) (Novichkov et al., 2013). (D) E. coli FadR represses fad expression, but activates
transcription of fabA/B and iclR on the condition without acyl-CoA thioesters. (E) Presence of long chain acyl-CoAs releases E. coli FadR protein from its cognate
targets, resulting in an induction of fad expression and transcriptional inactivation of fabA/B and iclR. (F) Vibrio FadR represses the expression of limited fad members,
whereas only activates fabA transcription on the condition with poor acyl-CoA species. (G) The generated long chain acyl-CoAs releases Vibrio FadR protein from its
cognate targets, which consequently induces the expression of limited fad members, whereas only inactivates fabA transcription. The three representative genes
(vc2105, fadBA, and fabA) are highlighted in bold and italic letters, whose ability of binding the Vibrio FadR regulator is demonstrated with EMSA (and/or SPR). The
gray oval denotes E. coli FadR regulatory protein whereas the green oval denotes Vibrio FadR regulator. The small red circle represents the acyl-CoA pool. E. coli
FadR has only one ligand-binding site in each monomer, whereas Vibrio FadR has two ligand-binding sites in each monomer.
FIGURE 2 | Binding of fabA to four types of FadR regulatory proteins. (A) Gel filtration analyses for interaction of EcFadR with fabA. (B) Use of EMSA assays to detect
interplay between fabA and VcFadR. (C) EMSA-based analyses for interaction of fabA with VpFadR. (D) Physical evidence for binding of ValFadR to fabA. The gel shift
experiments were carried out using 9% native PAGE, and a representative result from no less than three independent experiments is given. In each assay (15 µl in
total), the fabA probe (5 pmol) is supplemented, and varied level of FadR protein is indicated in the right hand five lanes of each panel (left to right) (2, 5, 10, 15, and 20
pmol). The four types of FadR proteins referred to EcFadR, VcFadR, VpFadR and ValFadR, respectively. The minus sign denotes the absence of FadR protein. FadR
protein at high level precipitates easily in the wells of gel or triggers super-shift in the gel shift experiments.
(Figure 2C). Of note, super-shift bands appeared in the cases
of VcFadR (Figure 2B) and ValFadR (Figure 2D). In addition,
surface plasmon resonance (SPR) results showed clearly that
the fabA probe binds to both EcFadR (Figure 3A) and ValFadR
(Figure 3B) in the dose-dependent manner. The binding affinity
of fabA to EcFadR and ValFadR is estimated to be 5.59 × 10−7
M (Figure 3A) and 2.58 × 10−7 M (Figure 3B), respectively.
Indeed, we recently extended fad regulon to a newly-identified
auxiliary fadmember, vc2105 ofV. cholerae (equivalent to vp0834
of V. parahaemolyticus) (Novichkov et al., 2013; Gao et al.,
2016). Therefore, we believed that ValFadR is functional and its
regulatory role is relatively-conserved (Figure 1).
Distinct Ligand-Binding Manner of ValFadR
and EcFadR
Consistent with earlier observations with EcFadR (Feng and
Cronan, 2010, 2012) and VcFadR (Feng and Cronan, 2011),
in vitro gel shift assays illustrated that only Long-chain fatty
acyl-CoA species [e.g., palmitoyl-CoA (C16:0), palmitoleyl-
CoA (C16:1), stearoyl-CoA (C18:0), and oleoyl-CoA (C18:1),
in Figure S3] release the ValFadR protein from its cognate
DNA, whereas the medium-chain fatty acyl-CoA thioesters [such
as nonanoyl-CoA (C9:0) and decanoyl-CoA (C10:0)] cannot.
However, it is not clear why the Vibrio FadR and EcFadR
differ greatly in the amplitude of fatty acid sensing. Given that
isothermal titration calorimetry (ITC) can give clues to different
binding modes of small molecules to a certain protein and the
equilibrium dissociation constants (Kds), we adopted the ITC
method to monitor palmitoyl-CoA (C16:0) ligand binding to the
three Vibrio FadR proteins (plus EcFadR) (Figure 4, Figure S4).
Comparative analyses of the ITC profiles clearly showed that
each EcFadR monomer binds palmitoyl-CoA ligand at the
ratio of 1:1 (Figure 4A), which is consistent with the scenario
seen with structure of E. coli FadR liganded with myristoyl-
CoA (Figures 6A,B) (van Aalten et al., 2001). In contrast,
each monomer of ValFadR bound 2 molecules of palmitoyl-
CoA (Figure 4B). As anticipated, the similar ligand-binding
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FIGURE 3 | SPR-based assays for binding of fabA to the FadR regulator. (A) SPR analysis of the E. coli FadR binding to the fabA promoter. (B) SPR assay for the
V. alginolyticus FadR binding to the fabA promoter. SPR assays were conducted to study the affinity and kinetics of FadR proteins and a representative result is given
regarding to EcFadR and ValFadR. FadR protein at various concentrations (typically 31.25–1,000 nM) were injected over the immobilized DNA probe covering the
FadR palindrome of fabA gene. The immobilization level of fabA is 34 RU. KD, kd/ka, ka, association constant; kd, disassociation constant; RU, response units.
FIGURE 4 | ITC-based evidence for distinct binding pattern of the palmitoyl-CoA ligand to FadR regulatory protein from E. coli and Vibrio alginolyticus. (A) ITC profile
of the E. coli FadR binding its ligand palmitoyl-CoA. (B) The use of ITC to assay interplay between the V. alginolyticus FadR and its ligand palmitoyl-CoA. Ec, E. coli;
Val, V. alginolyticus.
pattern was also seen in VcFadR (Figure S4A) and VpFadR
(Figure S4B). In addition, the ITC measurements showed that
the binding of Vibrio FadRs (VcFadR, VpFadR, and ValFadR)
palmitoyl-CoA (Figure 4B, Figure S4) are 4- to 10-fold higher
than that of EcFadR (Figure 4A) [the value of Kd1 exhibited
appreciably lower (3.17-fold for ValFadR (Figure 4B), 7.07-
fold for VcFadR (Figure S4A), and 5.06-fold for VpFadR
(Figure S4B)]. Obviously, it was consistent with the fact that
Vibrio FadR is a much more efficient regulator than E. coli FadR
(Iram and Cronan, 2005). Together, our ITC findings suggested
that ligand-binding of Vibrio FadR is in a manner distinct from
that of EcFadR (Figure 4, Figure S4), which is consistent with
the scenario seen in structure of VcFadR reported by Shi et al.
(Shi et al., 2015).
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FIGURE 5 | Structural comparison of the FadR proteins of V. cholerae and V. alginolyticus. (A) Ribbon structure of the dimeric FadR protein of V. cholerae. (B) X-ray
structure of the V. alginolyticus FadR protein in dimer. (C) Structural superposition of the two FadR proteins from V. alginolyticus and V. cholerae. Vc, V. cholerae; Val,
V. alginolyticus.
FIGURE 6 | Chemical structures of the representative FadR ligands and structural comparison of the liganded-ValFadR with the EcFadR-ligand complex structure.
(A) Chemical structures of LC fatty acyl-CoAs, the ligands for FadR regulatory proteins. The palmitoyl-CoA ligand that was successfully crystalized into the FadR
protein is highlighted in orange, whereas the double bond is indicated in blue. (B) Complex structure of the monomeric form of EcFadR liganded with myristoyl-CoA
ligand. The architecture of the EcFadR (PDB: 1H9G) is shown in blue cylinder, whereas the ligand of myristoyl-CoA is given in orange stick. (C) Complex structure of
the monomeric form of ValFadR liganded with palmitoyl-CoA ligand (PDB: 5DV5). The protomer form of ValFadR is shown in cyan cylinder, and the extra-40aa insert is
given in magenta. The ligands are shown in sticks, one of which is of light green in the binding site 1 and the other one present in site 2 is indicated in red.
(D) Superposition of the monomeric structure of ValFadR-ligand and EcFadR-ligand structure via their C-terminal ligand-binding domains.
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Overall Architecture of ValFadR
In our pilot trials of protein crystal screening, only the ValFadR
amongst the three Vibrio FadR proteins (VcFadR, VpFadR,
and ValFadR) is successful. The structure of apo-ValFadR was
determined at 2.35 Å (Table 1). In an agreement with those
of our gel filtration (Figure S2), ValFadR forms a dimer and
belongs to space group of P43212, in which each asymmetric unit
contains one FadR protomer (Table 1, Figures 7A,D). Solution
structure of dimer is consistent with the previously-reported
EcFadR (van Aalten et al., 2000) and VcFadR (Shi et al., 2015)
(Figure 5, Figure S5). The analyses of structural superposition
suggested that overall architecture of ValFadR (Figure 5B) can
match well that of VcFadR (Figures 5A,C). The protomer is
composed of two functional domains, the N-terminal DNA-
binding domain, the C-terminal ligand-binding domain and one
linker connecting these two domains (Figure S5). The N-terminal
DNA-binding domain adopts a typical wHTH fold motif and
includes three α helices (α1, α2, α3) and two β strands (β1 and β2)
(Figures S1, S5). The C-terminal ligand binding domain forms
an α-helix bundle and includes eight helices (Figures S1, S5).
Sequence alignment revealed that ValFadR has more 40 residues
(138–177 aa) insertion between helices α6 and α7 than EcFadR
(Figure S1). The ValFadR structure shows that these 40 residues
elongate helices α7, and form two helices, αA and αB, and some
linking loops (Figures S1, S5B,E), which is generally similar
to that of VcFadR alone (Figure 5) (Shi et al., 2015). Except
the insert of 40 residues, the structure of apo-ValFadR (Figures
S5B,E) is highly similar to that of apo-EcFadR (Figures S3A,D)
with r.m.s.d over 223 Cα atoms (one protomer) of 1.5 Å
(Figures S5C,F).
Structure of ValFadR Liganded with
Palmitoyl-CoA
Unlike the fact that VcFadR was complexed with the ligand
oleoyl-CoA (Shi et al., 2015), we obtained the crystal of ValFadR-
liganded with palmitoyl-CoA that was diffracted by X-ray to
2.4 Å (Table 1). The asymmetric unit contains one ValFadR
dimer and four palmitoyl-CoA molecules, in a 1:2 stoichiometry
(Figures 6C, 7B,E) as reported for VcFadR (Shi et al., 2015),
whereas EcFadR binds one molecule of ligand (myristoyl-CoA)
per monomer (Figures 6A,D). It fully validated the general
conclusion from the aforementioned ITC experiments (Figure 4,
Figure S4). The two ligand-binding sites in ValFadR are similar
to those observed with VcFadR (Figure S6) (Shi et al., 2015).
One of the ligand molecules binds to ValFadR in the site that
is equivalent to EcFadR ligand-binding site (designated site 1),
and the second ligand binds to the pocket derived in part from
the 40-residue insertion region. The site 1 is mainly formed
by the C-terminal domain (Figures S6A,B), whereas the site
2 is formed by both the N- and C-domains (Figures S6C,D).
The electron density of the acyl group in the ligand in
site 1 is well defined whereas the phosphorylated adenosine
head group is not clear (Figures S6A,B). The phosphorylated
adenosine head of the palmitoyl-CoA ligand in one protomer
interacts with several residues from the other protomer, including
hydrogen bonds between Arg245 and the phosphate group. The
TABLE 1 | Statistics on data collection and structure refinement.
Native Palmitoyl-CoA complex
DATA COLLECTION
Diffraction source Rigaku MicroMax007HF Rigaku MicroMax007HF
Space group P43212 P21
CELL DIMENSIONS
a, b, c(Å) 76.00, 76.00, 144.41 52.78, 88.48, 61.65
α, β, γ(◦) 90, 90, 90 90, 93.13, 90
Wavelength(Å) 1.5418 1.5418
Resolution range(Å)a 18.47–2.35 (2.48–2.35) 61.55–2.40 (2.53–2.40)
Unique reflection 17,995 (2,322) 20,456 (2,570)
Redundancy 4.8 (4.7) 4.5 (4.1)
I/σ 14.0 (3.4) 8.7 (1.9)
Completeness (%) 97 (98.6) 92.7 (84.1)
Rmerge (%)b 7.1 (41.0) 6.9 (39.3)
STRUCTURE REFINEMENT
No. of reflections (working) 16,195 18,435
No. of reflections (test) 1,800 2,021
Rcryst/Rfree(%) 21.8/25.6 19.0/24.7
No. of total atoms 2,312 4,675
No. of non-H protein atoms 2,200 4,328
No. of Ni2+ 1 –
No. of palmitoyl-CoA atoms – 260
No. of water molecules 111 87
Average B-factors(Å2): 72 49
Protein 72 48
Ni2+ 45 –
Palmitoyl-CoA – 62
Water 51 41
RMS DEVIATION FROM IDEAL GEOMETRY
Bond length(Å) 0.003 0.002
Bond angle(◦) 0.663 0.677
RAMACHANDRAN PLOT (%)
Most favored regions 95.91 95.66
Additional allowed regions 4.09 3.58
Generally allowed regions 0 0
Disfavored regions 0 0.75
aValues in the parentheses are for the data in the highest resolution shell.
bRmerge =
∑
|Ii − Im |/
∑
Ii , where Ii is the intensity of the measured reflection, and Im is the
mean intensity of all of the symmetry-related reflections.
pyrophosphate group interacts with residues of both Arg253
and Tyr115 via hydrogen bonds (Figures S6A,B). For the ligand
in site 2, the phosphorylated adenosine head group is well
defined in electron density while the acyl group lack this
ability (Figures S6C,D). The phosphorylated adenosine head
group inserts into the pocket derived from the part of the
40-residue insertion region. Among it, the adenosine group
stacks with residues Tyr153 and Met187 and forms hydrogen
bond with Asn130 and Tyr184. The phosphate group forms
hydrogen bond with residue Lys156 and the pyrophosphate
forms hydrogen bond with residues Arg126 and Arg191
(Figures S6C,D).
Structural comparison revealed that the C-terminal domain of
ValFadR is distinctly varied from that of EcFadR-ligand complex
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FIGURE 7 | Structural comparison of the apo- and ligand bound-FadR protein from V. alginolyticus. Monomeric (A) and dimeric (D) structures of apo-ValFadR protein
are shown in magenta cylinder (PDB: 5XGF). Protomer (B) and dimeric (E) structures of ligand-bound ValFadR protein are shown in cyan cylinder (PDB: 5DV5). The
monomeric (C) and dimeric (F) structures of the apo- and ligand-bound ValFadR protein are superposed via their C-terminal ligand-binding domains. The ligand in
binding site 1 is shown in gray spheres and the other one in binding site 2 is indicated with orange spheres. Val, V. alginolyticus; N, N-terminus of the FadR protein;
C, C-terminus of the FadR protein.
structure (Figure 6D), which is due to the different stoichiometry
of ligand binding, with an r.m.s.d larger than 3 Å over 100 Cα
atoms. In contrast, the N-terminal domain is similar to that of
EcFadR with an r.m.s.d 1.0 Å over 70 Cα atoms (Figure 6D).
The major difference between ValFadR and EcFadR lies in the
N-domain orientations. The second ligand-binding site involves
some residues of the N-terminal domain (Figures S6A,D) and
the bound second ligand made the N-domain could not take
the similar orientation observed in apo-ValFadR and EcFadR
(Figures 6B–D). The large-scale movement of the N-domain
leads to distance changes between the twoDNA-binding domains
of the protein dimer and places the domains in a conformation
not suitable for DNA binding. It represents structural basis for
ligand-triggered ValFadR-DNA dissociation.
Conformational Alteration of ValFadR by
Ligand Binding
Structure superposition showed that the major difference
between apo-ValFadR (Figures 7A,D) and liganded-ValFadR
(Figures 7B,E) lies in the varied N-domain orientations
(Figures 7C,F). Similar scenario also occurred between ligand-
bound ValFadR and ligand-bound EcFadR (Figures 6B–D).
To illustrate the mechanism whereby ligand-binding leads to
the conformational change, both domains of apo-ValFadR and
ligand-bound ValFadR are superposed. The N-domains show
similar conformations with r.m.s.d 0.9 Å over 65 Cα atoms,
so do the C-domains with r.m.s.d 1.3 Å over 173 Cα atoms
(Figures 7C,F). These results suggest that the ligand-binding
does not alter the overall conformation of both domains but
mainly changes the orientation of N-domain (Figures 7C,F).
The ligand in the site 1 does not interact with the N-terminal
domain and the linker helix, indicating that this ligand-binding
does not contribute to the large-scale domain swing. Also,
there is no significant domain movement observed in EcFadR
upon the ligand-binding (equivalent to site 1 of ValFadR).
The ligand in the site 2 interacts with helix α4 of the linker.
Interestingly, this helix α4 exists as a standard helix without a
B factor significantly higher than the other local residues and
did undergo a conformational change from helix to loop upon
ligand binding (Figures S6C,D), which is quite different from
that of VcFadR (Shi et al., 2015). The second ligand wedged into
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the interface of N- and C- domain via its acyl chain tail and alters
the orientation of helix α4 as well as the N-domain, which is
proposed to be a major reason for the large-scale domain swing
upon binding the second ligand. Also, the additional ligand
in one protomer interacts with many residues from the other
protomer as described above, which definitely affects the dimeric
interface and causes slightly relative movements between two
protomers.
Physiological Roles of Vibrio FadR and the
Additional Ligand-Binding Site 2
Genetic amenability in V. cholerae allowed us to create the
1fadR deletion mutant, using the method of homologous
recombination (Figure S7A). Following PCR-based
identification, we harvested the interested 1fadR mutant
(Figure S7B). Given the fact that the ligand-binding site 2 of the
Vibrio FadRs is mainly involved in the insertion of 40-residues
(138-177aa, Figure S1, Figure 5), we therefore designed a
site 2-deficient fadR mutant (142 without 136-177aa) and
engineered it into the 1fadR mutant of V. cholerae. Functional
complementation with the wild-type and/or 142 mutant of
fadR gene into the 1fadR to probe the in vivo role of fadR and
the ligand-binding site 2 in the context of lipid metabolism in
V. cholerae.
First, western blot analyses with anti-VcFadR rabbit sera as
primary antibody showed that the wild-type of fadR gene and
its derivative [i.e., the fadR (142) mutant] can express well in
V. cholerae, whereas not in the1fadRmutant strain ofV. cholerae
(Figure 8A). Subsequently, LacZ-based transcriptional assays
revealed that fabA expression is decreased dramatically in the
1fadR mutant of V. cholerae, and can be enhanced greatly upon
over-expression of the wild-type V. cholerae fadR (Figure 8B).
This result confirmed that FadR acts as an activator for the
fabA gene of UFA synthesis in Vibrio. Of note, the fadR (142,
lacking the site 2) mutant gene failed to restore fabA transcription
(Figure 8B), implying the site 2-containing region is critical for
VcFadR function. Further analyses of fatty acids composition
from Vibrio membrane phospholipids showed that (i) UFA/SFA
ratio in the 1fadR mutant (Figures 9B,E) is relatively lower
than that of the wild-type strain (Figures 9A,E), (ii) this ratio
can be restored in the complementary strain (C1fadR+VcfadR)
(Figures 9C,E); and (iii) the fadR (142) mutant gene without
the site 2 cannot (Figures 8D,E). Therefore, we believed that
the Vibrio FadR does control/remodel membrane integrity
determined by the ratio of UFA to SFA incorporated into bacterial
membrane phospholipids (Figure 9) via its positive regulation of
the fabA transcription (Figure 8).
Roles of Vibrio FadR and the
Ligand-Binding Site 2 in Bacterial Virulence
Similar to the phenotype of the fadR insertional mutant strain of
V. vulnificus (Brown and Gulig, 2008), the fadR deletion mutant
strain of V. cholerae also displays slower growth in LB liquid
media and colony of smaller size on LBA plates than the wild-type
strain (Figure S8, Figure 9A). The growth/morphological defects
were significantly restored by both plasmid-borne expression of
the wild-type VcFadR (Figure S8) and the addition of exogeneous
oleate (Figure 10A). However, the expression of fadR (142) with
ligand-binding site 2 deleted (Figure 8A) failed to complement
the phenotype of defective growth (Figure S8). In light that
fadR (142) mutant neither augments the decreased expression
of fabA, an important gene for UFA synthesis (Figure 8B),
FIGURE 8 | FadR activates expression of fabA, an important gene for unsaturated fatty acid synthesis in V. cholerae. (A) Western blot analyses for fadR expression
and its derivatives. The primary antibody used here is rabbit sera against V. cholerae FadR. (B) The beta-gal activity of fabA-lacZ transcription fusion is significantly
decreased in the 1fadR mutant, and can be restored by the functional complementation of the wild-type fadR [but not VcfadR(142)]. The fadR deletion mutant strain
referred to 1fadR, and the two types of complemented strain of 1fadR used corresponded to C1fadR + VcfadR and C1fadR + VcfadR(142), respectively. The
VcfadR(142) denoted an engineered version of V. cholerae fadR with a 42-residue deletion covering the site 2 for ligand binding. Log-phase cultures were collected
for assaying the LacZ activity. The β-gal activity is expressed as the mean ± standard deviation and is collected from no less than three independent experiments.
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FIGURE 9 | Systematic analyses of fatty acid profile suggests that functional alteration of the Vibrio FadR remodels structure of bacterial membrane phospholipids.
(A) Analyses for the fatty acid composition isolated from the wild-type strain of V. cholerae. (B) Alteration in the fatty acid compositions in the 1fadR mutant of V.
cholerae. (C) The fatty acid profile in the complemented strain of 1fadR mutant with plasmid-borne V. cholerae fadR. (D) Failure to recover the fatty acid composition
of the V. cholerae 1fadR strain using plasmid-driven expression of the V. cholerae fadR derivatives that lack the second ligand-binding site [designated as
VcfadR(142)]. (E) Effects on UFS/SFA ratio of membrane phospholipids by FadR regulatory protein in V. cholerae. *Student t-test p < 0.01.
nor rescues the dysfunction in fatty acid composition of
phospholipids in the 1fadR mutant strain of V. cholerae
(Figures 9D,E), we favored to hypothesize that the activation of
fatty acids synthesis by FadR has significant impacts on bacterial
growth and the ligand-binding site 2 is critical for FadR function
in vivo.
Given that the opportunistic pathogen V. vulnificus FadR
is necessary for bacterial infection in mice (Brown and Gulig,
2008), it is of much interest to test if site 2 has a role
in virulence-associated traits as well as infection competency
in V. cholerae (Figures 10, 11). Thus, we examined the
possible relevance of fadR (and/or the ligand-binding site 2)
to bacterial swarming, a virulence-associated trait. As expected,
the swarming ability was impaired greatly upon the removal
of fadR from V. cholerae (Figure 10B) (Brown and Gulig,
2008). Functional complementation with VcFadR recovered
it to that of the parental strain (Figure 10B). Although the
expression of VcFadR (142) (Figure 8A) failed to complement
the loss of swarming ability, supplementation of exogenous
oleate rendered them indistinguishable in the swarming assays
(Figure 10C). We therefore anticipated that dysfunction of
swarming/mobility is related to altered surface architecture of
membrane phospholipids. Subsequently, we performed infant
mouse colonization competition assays (Gardel and Mekalanos,
1996). To rule out the possible effects of delayed growth of1fadR
mutant, we subjected them to the in vitro colonization trials
on LBA plates supplemented with oleate prior to colonization
experiments of mice in vivo. The result showed that the delayed
growth phenotype of the1fadRmutant does not affect greatly the
in vitro output [i.e., the ratio of colony numbers (WT/1fadR)]
(Figure S10). Thus, we compared the colonization abilities of
the wild-type strain with the 1fadR mutant strain and the
complementary strain of fadR mutant (with either wild-type
fadR or fadR [142, lacking site 2]). We found that the 1fadR
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FIGURE 10 | Oleate can rescue the defection of bacterial growth and swarming caused by the inactivation of FadR. (A) The 1fadR mutant exhibited the phenotype of
small colony size, and growth defect was restored by an addition of oleate into LB media. The two V. cholerae strains used here included WT (C6706) and FYJ639
(1fadR). Bacterial cultures in serial 10-fold dilutions were spotted (from top to bottom) on plates of LBA solid medium, and kept at 37◦C for 18 h. On the LBA plate
without any addition of oleate (Left panel), the single colony size of 1fadR is much smaller than that of the wild-type. However, the colonial size of the two strains is
comparable upon the supplementation of oleate (Right panel) into the LBA plates. The typical colonies are indicated with red arrows. A representative result is given.
(B) The ability of bacterial swarming, a virulence-associated trait, was impaired by the deletion of VcFadR, but rescued by the functional complementation of the
wild-type fadR (but not fadR(142)) and in vitro supplementation of oleate can rescue (C). For the swarming assays, the log-phase culture appropriately diluted (∼10 ul)
is spotted on semi-solid 0.3% agar LB plates and kept overnight at 37◦C.
mutant is profoundly defective in colonization (the competitive
index is around 0.004) (Figure 11), suggesting that FadR plays
a critical role in V. cholerae virulence. Complementation with
the wild-type fadR partially restored colonization of 1fadR,
whereas the plasmid containing fadR (142) failed to recover
the 1fadR colonization (Figure 11). It seems possible that the
site 2-containing region (42-residues long, 136-177aa) is critical
for V. cholerae FadR as a functional virulence factor. In fact,
we also noted expression of the two major virulence factors
ctxA (Figure S9A) and ctpA (Figure S9B) are slightly inhibited
by inactivation of fadR. This control of virulence factors was
assigned by Kovacikova et al. (2017) to the indirect modulation
of ToxT by FadR via two different mechanisms. Hence, our
findings might be additional to the linker of bacterial fatty acid
metabolism and Vibrio pathogenesis.
DISCUSSION
Different organisms have developed diversified mechanisms
to tightly modulate fatty acid synthesis as fatty acids are
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FIGURE 11 | Roles of V. cholerae FadR and the new ligand-binding site 2 in
bacterial virulence. Effects exerted by V. cholerae FadR on colonization in the
infant mouse model. 1fadR mutants containing vector control, VcfadR and
VcfadR (142) were co-inoculated into infant mice with wild-type at 1:1 ratio.
After 18-h colonization, the colonized bacteria were enumerated on selective
agar plates. Competitive index is calculated as output ratio of mutant to
wild-type normalized against input ratio of mutant to wild-type. Horizontal line:
mean of CI. **Student t-test p < 0.01; ns, no significance.
energetically-expensive molecules to produce. To date, six
bacterial transcription regulators have been identified. Three of
them [FapR (Schujman et al., 2003), DesR (Aguilar et al., 2001;
Zhu et al., 2006), and FabT (Lu and Rock, 2006)] are found in
Gram-positive bacteria, while the other three members [FadR
(Henry and Cronan, 1991; Cronan and Subrahmanyam, 1998;
Campbell and Cronan, 2001), FabR (McCue et al., 2001; Zhang
et al., 2002), and DesT (Zhang et al., 2007)] are derived from
Gram-negative bacteria. Unlike the prototypical version of FadR
regulatory protein, the E. coli fadR protein product (van Aalten
et al., 2000, 2001; Xu et al., 2001), the description of three
Vibrio FadR homologs (ValFadR, VpFadR, and VcFadR) from
our groups and recent report by Shi and coworkers (Shi et al.,
2015) defined a unique mechanism for bacterial fatty acid sensing
in the genus of Vibrio (Figure 1). Although the Vibrio FadR
proteins were derived from different species (V. alginolyticus
from our group and V. cholerae for Kull’s group), the structures
we obtained are almost identical, both of which underlined
that the insert of 40-residues constitute an extra-domain rich
in α-helix (Figures S1, S5, Figure 5). Further dissection for
two types of Vibrio FadR-ligand complexes [ValFadR/Palmitoyl-
CoA (C16:0) from our group plus VcFadR/Oleoyl-CoA (C18:1)
from F. Jon Kull’s group] consistently reveal that the so-called
“40-aa insert” of Vibrio FadR regulatory protein constitutes
the second ligand-binding site in that it already retained the
ligand-binding site 1 that is highly similar to that of E. coli
FadR (Figure 6, Figure S6). This scenario seen with Vibrio
FadR regulator sounds unusual, but not without precedent in
that (i) the cAMP-receptor protein (CRP) requires binding of
two cAMP molecules each monomer for its function (Passner
and Steitz, 1997); (ii) BenM, a LysR-like regulator, has two
ligand-binding sites for effector benzoate (Ezezika et al., 2007).
Subsequently, the question raised is what could be a physiological
explanation for this unique mechanism. We speculated that
unlike the paradigm enteric bacterium E. coli colonizing the
digestive tract rich in fatty acids, Vibrio species residing in
aquatic environments with low level of fatty acids precipitated
on the sediment (Giles et al., 2011) have to evolve a more
efficient system for fatty acid uptake, rendering its fatty acid-
responsive FadR regulator to select an additional ligand-binding
site.
Indeed, complex structures of two types of the ligand/Vibrio
FadR from our group (Figure 4, Figure S5) and report by Shi et al.
(2015) allow us to better understand the structural/molecular
basis for crosstalk/response of Vibrio FadR to effectors. As
illustrated in Figure 6 and Figure S6, the head of CoA for the
second ligand is well fixed and recognized, and the tail of fatty
acid chain is inserted between N-terminus and C-terminus of
ValFadR and a two-body interface. That is why we hypothesize
that fatty acyl-CoA of different lengths might synergistically
interfere with Vibrio FadR. In the dimeric form of Vibrio FadR
protein, the ends of the four lines of fatty acyl chains converge
at the same point, which determine the inability of the limited
space to hold fatty acyl chains withmuch longer length. Probably,
the acyl chain of both C16 in ValFadR (Figure 6, Figure S6),
and C18 in VcFadR (Shi et al., 2015) seemed to be quite close
to the its length limit. The fact that extensive ligand-triggered
conformation changes seen with two FadR proteins (ValFadR and
VcFadR, Shi et al., 2015) more completely impaired the DNA
binding than that of E. coli FadR protein, provided structural
explanation for our former observation that addition of oleate
can result in almost full de-repression of Vibrio fad regulon, like
fadBA (Iram and Cronan, 2005). Not only have we elucidated
the contribution of the extra 40-aa insert to the function of
Vibrio FadR protein in the context of lipid metabolism, but
also discovered its relevance to bacterial infections (Figures 10,
11). Additionally, the uniqueness of this insert inVibrio might
determine that the fatty acid sensing by FadR with double
ligand-binding sites is exclusively distributed into the phylum of
Vibrionaceae from È-proteobacteria.
Together with the recent Kavocikova’s discovery that virulence
control by V. cholerae FadR is due to indirect cross-
talking with ToxT, a master virulence regulator, via two
independent mechanisms (Kovacikova et al., 2017), our results
constituted additional input to better understanding of link
between fatty acid metabolism and bacterial pathogenicity, i.e.,
membrane integrity of phospholipids is crucial for bacterial
competitive colonization. The structural characterization of
ValFadR regulator defines an additional example in the context
of the diversified regulation of bacterial fatty acid metabolism
(Marrakchi et al., 2002; Zhang and Rock, 2009). We hypothesized
that the Vibrio FadR regulator has evolved this additional ligand-
binding site to gain an advantage of infection competency in
bacterial-host battle. Given the significant contribution of FadR
regulatory protein to pathogenesis of certain Vibrio species, it
is possible that development of small molecule drugs/inhibitors
targeting the FadR-mediated mechanism for bacterial fatty acid
sensing might be efficient therapeutics against severe infections
by the zoonotic Vibrio pathogens.
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MATERIALS AND METHODS
Ethics Statements
Animal care and treatment were conducted in accordance with
institutional guidelines and the protocols at Zhejiang University,
China. Five-day-old CD1 mice were housed in a temperature-
controlled room with proper darkness-light cycles, fed with a
regular diet, and maintained under the Experimental Animal
Center of Zhejiang University, China. The mouse experimental
design and protocols used here were approved by the Ethics
Committee of Zhejiang University, China (ZJU20170800).
Bacterial Strains and Growth Conditions
E. coli strains used here are derivatives of the wild-type K-12
strain (Table S1). Vibrio strains used here included V. cholerae
EI Tor C6706 (Joelsson et al., 2006), V. parahaemolyticus
ATCC 17802 and V. alginolyticus. E. coli SM10 (λ-pir) was
used as the donor strain for conjugations with V. cholerae.
These strains were routinely maintained in LB medium (Luria-
Bertani medium containing 10 g of tryptone, 5 g of yeast extract
and 10 g of NaCl per liter) or on LB agar plates (Feng and
Cronan, 2011). LB without NaCl and containing 6% (wt/vol)
sucrose was used for a selection of the strain with homologous
recombination. The growth temperatures used are either 30◦
or 37◦C. When necessary, antibiotics were added as follows
(in µg/ml): tetracycline, 20 for E. coli and 2 for V. cholerae;
ampicillin, 100; kanamycin, 50; and streptomycin, 100 (Feng and
Cronan, 2009a).
Plasmids and DNA Manipulations
V. cholerae fadR gene was previously cloned pET16b vector (Iram
andCronan, 2005). The two fadR genes fromV. parahaemolyticus
and V. alginolyticus were separately amplified with PCR. They
were directionally cloned into the pET28 expression vector. The
resultant recombinant plasmids were introduced into E. coli
BL21 (DE3) for large-scale production of the FadR protein. As
we previously described in the synthesis of the Brucella bioR
gene in vitro with little change (Feng et al., 2013), overlapping
PCR was used to create a mutant fadR gene (fadR(142)) with
the deletion of 42 residues (136-177aa). The pWM91 vector is
applied for construction of fadR knock-out plasmid (Metcalf
et al., 1996). The expression plasmid pBBR1-MCS3 is used
for functional assays of the fadR gene in different versions
(VcfadR and the VcfadR mutant 142), Table S1) in V. cholerae
(Kovach et al., 1995). All plasmid constructs were validated
by PCR detection (Table S2) and direct DNA sequencing
(Zhang et al., 2014).
In-Frame Deletion of V. cholerae fadR and
Genetic Complementation
V. cholerae El Tor C6706 (Joelsson et al., 2006) was used as
the wild-type strain in this study unless otherwise noted. In-
frame deletions were constructed by cloning of the upstream (and
downstream) regions neighboring the target fadR gene (vc1900)
into the suicide vector pWM91 containing a sacB counter-
selectable maker (Metcalf et al., 1996). The upstream (and/or
downstream)DNA fragments (of 700 bp long) flanking fadRwere
amplified by PCR using the two pairs of specific primers (L-flank
fadR-5′/L-flank fadR-3′ and R-flank fadR-5′/R-flank fadR-3′)
with the high-fidelity Prime STAR DNA Polymerase (Table S2).
The flanking DNA sequences in the upstream (and downstream)
of the fadR were overlapped and cloned into the two restriction
sites of pWM91 (SacI and BamHI), giving knockout plasmid
pWM91-fadRKO. Then the plasmid was introduced into the
V. cholerae strain by conjugation from SM10 (λ-pir) and a single
crossover event was selected by resistance to streptomycin and
ampicillin. The selection growth in the absence of ampicillin and
streptomycin assures that double crossover events occur. Finally,
the 1fadR mutant was given via sucrose-based screening. The
proper genetic exchange event was confirmed by multiplex-PCR
and direct DNA sequencing.
For functional complementation, the wild-type fadR gene
of V. cholerae plus its VcfadR mutant (fadR(142)) were
directionally inserted into the pBBR1-MCS3 vector via the two
sites (KpnI and XbaI), giving plasmids like pBBR1-MCS3-fadR
(Table S1). The resultant plasmids were transformed into E. coli
SM10 (λ-pir), and then conjugated into the V. cholerae 1fadR
mutant. Tran-conjugants were selected on LB plates containing
streptomycin and tetracycline. All the constructs were verified by
direct DNA sequencing of PCR products.
Anti-FadR Rabbit Sera and Western Blot
Anti-sera against VcFadR were prepared as previously described
(Shao et al., 2011). Pre-immune sera were collected from New
Zealand White rabbits (female, 1.5 kg) and then animals were
injected subcutaneously at multiple sites with approximately 1
mg/kg of purified FadR recombinant protein emulsified with
Freund’s complete adjuvant (1:1). After 2 weeks, each rabbit
received the first booster injection with the same antigen
concentration emulsified with Freund’s incomplete adjuvant
(1:1). One week later, each rabbit received the second booster
injection with the same antigen concentration emulsified with
Freund’s incomplete adjuvant (1:1). Then, anti-serum samples
were collected when the booster injection was administered
7 days later. The sensitivity and specificity of antibody were
evaluated routinely by ELISA and Western blot (Feng and
Cronan, 2009b). Using the rabbit sera against VcFadR protein
as primary antibody, Western blotting analyses were conducted
to detect expression of fadR gene (and its derivatives) in the
wild-type (or1fadRmutant) strain of V. cholerae.
Growth Phenotypes and Swarming Assays
Growth phenotypes of V. cholerae and its derivatives were
examined using both LBA solid plates and measurement of
growth curves. To determine effect of colony size by the deletion
of fadR, bacterial cultures in series of 10-fold dilution were
spotted on solid LBA plates and maintained overnight at 37◦C.
Similarly, the cultivation of V. cholerae species in liquid LB
media at 37◦C was monitored for plotting the growth curves. For
swarming assays, log-phase cultures were diluted appropriately
(10 µl each) is spotted on semi-solid 0.3% agar LBA plates and
kept overnight at 37◦C prior to visualization of mobility. Over
three independent trials were conducted.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 13 December 2017 | Volume 7 | Article 513
Gao et al. Characterization of the V. alginolyticus FadR
Assays for Competition Colonization in
Infant Mice
Following the protocol established by Davies et al. (2011) with
minor modifications, we evaluated the role of fadR in bacterial
virulence through the competitive colonization experiments in
the model of infant mouse. Briefly, the wild-type strain of
V. cholerae (either C6706 or C6706 lac−) and its mutants
were cultivated on LBA plates with streptomycin (100µg/ml)
overnight at 37◦C. The wild-type and mutant strains were
mixed together in LB medium. 100 µl of competition mixtures
(about 1 X 105 CFU) were inoculated into a 5-day-old CD1
infant mouse. Serial dilutions of the competition mixture were
plated on LBA plates with streptomycin (100µg/ml) as the
selective pressure and enumerated to determine the input ratio
of wild-type to the mutant strain. After incubation at 30◦C
for 18 h, the infant mice were sacrificed, and small intestines
were removed and homogenized in 5ml of LB. Serial dilutions
were plated on LBA plates containing streptomycin (100µg/ml)
and enumerated to determine the output ratio of wild-type to
the appropriate mutant strain. The competitive index for each
mutant is defined as the input ratio of mutant/wild-type strain
divided by the output ratio of mutant/wild-type strain.
Protein Expression and Purification
Since all the other three FadR proteins of Vibrio origins
were tagged with hexa-histidine on the N-terminus, similar
to the paradigm E. coli FadR protein stocked in our lab.
The recombinant proteins were routinely prepared as we
described before (Zhang et al., 2014). Briefly, when the optical
density at wavelength of 600 nm (OD600) reached 0.6, the
bacterial culture was induced with 0.2mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG) at 30◦C overnight. Following lysis
by sonication, the cell lysate was clarified by centrifugation
and loaded onto a nickel-ion affinity column (Qiagen). After
removal of contaminant proteins with washing buffer containing
50mM imidazole, the 6xHis-tagged FadR protein was eluted in
elution buffer containing 150mM imidazole, concentrated by
ultra-filtration (30-kDa cutoff) and exchanged into 20mM Tris-
HCl (pH 7.5) containing 100mM NaCl. The soluble fractions
were further purified by gel filtration with a Superdex 200 10/300
column (GL, GE Healthcare) and the resultant FadR proteins
were judged with 12% SDS-PAGE. Protein concentrations were
measured using the BCA method with BSA as internal reference
(Thermo Scientific).
Electrophoretic Mobility Shift Assays
As we described earlier with minor modifications (Zhang
et al., 2014), electrophoretic mobility shift assays (EMSA) were
conducted to test the binding of FadR protein to the DNA
targets. In this case, FadR protein of E. coli and Vibrio were
studied. The FadR-specific DNA probes is fabA probe which
is specific to the fatty acid biosynthesis fabA gene. The above
double-stranded DNA probe was generated by annealing the
two complementary primers in TEN buffer (10mM Tris-HCl,
1mM EDTA, 100mM NaCl; pH 8.0). Generally, the DNA probe
was mixed with/without FadR protein in binding buffer and
incubated at room temperature. The DNA-protein complexes
were separated with native PAGE gels (Feng and Cronan, 2011,
2012; Tang et al., 2014).
Surface Plasmon Resonance
To further address the interplay between FadR proteins and the
DNA target (such as fabA), surface plasmon resonance (SPR) was
employed using a Biacore3000 instruments (GE Healthcare) at
25◦C. For immobilization on an SA sensor chip, the biotinylated
DNA probe of fabA was specifically captured by streptavidin on
the surface. All the SPR experiments were run in the running
buffer (20mM Tris-HCl, pH7.5, 200mM NaCl and 0.005%
Tween 20) at the flow rate of 30 µl/min. A series of dilutions of
protein samples were injected and passed over the chip surface
for 2min. The dissociation phase was followed for 3min in the
same buffer, and the surface was then regenerated with 0.025%
SDS for 24 s. Kinetic parameters were analyzed using a global
data analysis program (BIA evaluation software), and final graphs
were further processed with Origin software.
Isothermal Titration Calorimetry
To study the binding of FadR protein to its effector molecule
like palmitoyl-CoA, isothermal titration calorimetry (ITC) was
conducted using aMicroCal iTC200 (Malvern) with a cell volume
of 200 µl. Both FadR samples and the ligand of palmitoyl-CoA
were dialyzed against the same buffer (20mM Tris-HCl pH7.5,
100mM NaCl) to minimize artifacts due to minor differences
of the buffer composition. Prior to titration, the sample of FadR
protein was injected into the cell, and the syringe was filled with
palmitoyl-CoA. All the ITC experiments were performed at 25◦C
with a reference power of 8 and a stirring speed of 1,000 rpm.
The final heat was corrected by subtracting the dilution heat from
palmitoyl-CoA titrated to buffer. The raw data was analyzed with
the Origin software (note: one set of sites for EcFadR, two sets of
sites for VpFadR and ValFadR, and sequential binding sites for
VcFadR).
β-Galactosidase Assays
To measure bacterial β-gal activity, log-phase cultures of
V. cholerae carrying the plasmid-borne pTL61T-PfabA-lacZ
transcription fusion grown in LB media (Table S1) were collected
by spinning and suspended in Z-buffer (Gao et al., 2016). The
data was obtained from three independent assays.
Protein Crystallization and Data Collection
All the apo-FadR homologs of three Vibrio species (ValFadR,
VpFadR, and VcFadR) were subjected to initial crystallization
trials at protein level of 10 mg/ml, using hanging-drop vapor
diffusion method at 16◦C. 1µl of protein solution was mixed
equally with the well solution. Consequently, crystals of apo-
ValFadR were observed on the condition containing 200mM
Calcium Acetate, 100mM Sodium Cacodylate pH 6.5 and 7%
PEG8000. After 2–3 days, crystals grew to dimension of 0.1mm
by 0.15mm by 0.1mm. To obtain the crystal of ValFadR complex
with ligand, a 2-fold molar excess of palmitoyl-CoA was added
to 10 mg/ml ValFadR solution, and incubated for 2 h at 16◦C
before crystallization. The crystals were grown on the condition
(4% Tacsimate, pH 5.0, 11% PEG3350) in 2 weeks. Crystal
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was transferred to cryo-protecting solution of mother liquor
containing 15% glycerol for a few seconds and then quickly
flash-cooled in liquid nitrogen and the dataset was collected
on a Rigaku R-Axis IV++ image plate using Cu Kα radiation
(λ= 1.5418 Å) at 100K.
Structure Determination and Refinement
Diffraction data of protein crystals was integrated and processed
using MOSFLM and SCALA from the CCP4 program suite
(Collaborative Computational Project, 1994). The structure
of ValFadR was determined by molecular replacement using
EcFadR structure (PDB: 1E2X) as a search model. The model
was first built automatically using PHENIX package (Adams
et al., 2002) and then manually with COOT (Emsley and Cowtan,
2004) and structure refinement was performed with Phenix.
For the structure of ValFadR and palmitoyl-CoA complex, the
apo-ValFadR structure was used as a search model and then
was built manually with Coot and refined with Phenix. The
stereo-chemical quality of the refined structures was verified with
PROCHECK (Morris et al., 1992). All structural representations
were prepared with PyMol (DeLano Scientific). The two PDB
accession numbers are listed as follows: 5XGF for ValFadR alone
and 5DV5 for ligand-bound ValFadR protein.
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